Novartis v. Ezra and Novartis v. Breckenridge: Cracks in the Armor of ODP Portending Well for Innovative Pharma?

December 9, 2018

Introduction
The Federal Circuit issued decisions in Novartis AG v. Ezra Ventures LLC, — F.3d __, 2018 WL 6423564 (CHEN, Moore, Stoll) and Novartis Pharmaceuticals Corp. v. Breckenridge Pharmaceutical, — F.3d __, 2018 WL 6423451 (CHEN, Prost, Wallach) on Dec.…

Chief Judge Stark Denies Defendants’ Motion for Judgment on Pleadings Seeking to Have Patent-in-Suit Ruled Invalid or Terminally Disclaimed

By Fox Rothschild LLP

September 24, 2016

By Memorandum Opinion entered by The Honorable Leonard P. Stark in Novartis AG, et al. v. Ezra Ventures, LLC, Civil Action No. 15-150-LPS (D.Del. September 22, 2016), the Court denied Defendant’s motion for judgment on the pleadings which argued that…